Data search


search
Exact
Search

Results for MligTC455_21743

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_21743 695 14.47 Mlig455_068753

Neo: -

Age: -

CYLD Mlig455_068753 {REF} {Length: 4221} {TRANSSPLICED} {Pfam: CAP-Gly domain [PF01302.27, score=33.5]} {Human: ENSG00000083799, CYLD, CYLD lysine 63 deubiquitinase, [RH, Score=285, Expect=8e-83]} {Mouse: ENSMUSG00000036712, Cyld, CYLD lysine 63 deubiquitinase, [RH, Score=286, Expect=2e-83]} {Dmel: FBgn0032210, CYLD, Cylindromatosis, [Score=300, Expect=2e-92]} {Celegans: WBGene00009594, cyld-1, CYLinDromatosis (Human disease gene) homolog, [RH, Score=190, Expect=4e-50]} {Smed: dd_Smed_v6_3043_0_1, dd_Smed_v6_3043_0_1, [Score=144, Expect=2e-35]} {RNA1509_13346, RNA1509_29655} {RNA1310_3957.1, RNA1509_29655} {RNA1509_29655, RNA815_1281.1}

Cumulative graph for MligTC455_21743

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.873 4.21 0.02697 0.42911
RegionR2 1.159 4.21 0.02150 0.16072
RegionR3 1.11 4.21 0.00427 0.08544
RegionR4 0.101 4.21 0.82811 1.00000
RegionR5 0.573 4.21 0.12336 0.35300
RegionR6 0.375 4.21 0.37517 0.95526
RegionR7 0.116 4.21 0.82236 1.00000
RegionR8 -0.562 4.21 0.40534 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -4.308 4.21 0.46453 1.00000
RegenerationR2 0.512 4.21 0.20437 0.65123
RegenerationR3 0.394 4.21 0.37055 0.78418
RegenerationR4 0.613 4.21 0.18486 0.62610
RegenerationR5 0.346 4.21 0.41065 0.80608
RegenerationR6 0.357 4.21 0.46000 0.77775
RegenerationBL 0.53 4.21 0.35953 0.72852
RegenerationTP 1.773 4.21 0.00108 0.04993


Genes with expression patterns similar to MligTC455_21743

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_21743 695 14.47 Mlig455_068753

Neo: -

Age: -

CYLD 6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_068753 {REF} {Length: 4221} {TRANSSPLICED} {Pfam: CAP-Gly domain [PF01302.27, score=33.5]} {Human: ENSG00000083799, CYLD, CYLD lysine 63 deubiquitinase, [RH, Score=285, Expect=8e-83]} {Mouse: ENSMUSG00000036712, Cyld, CYLD lysine 63 deubiquitinase, [RH, Score=286, Expect=2e-83]} {Dmel: FBgn0032210, CYLD, Cylindromatosis, [Score=300, Expect=2e-92]} {Celegans: WBGene00009594, cyld-1, CYLinDromatosis (Human disease gene) homolog, [RH, Score=190, Expect=4e-50]} {Smed: dd_Smed_v6_3043_0_1, dd_Smed_v6_3043_0_1, [Score=144, Expect=2e-35]} {RNA1509_13346, RNA1509_29655} {RNA1310_3957.1, RNA1509_29655} {RNA1509_29655, RNA815_1281.1}
2. MligTC455_18238 1037 21.6 Mlig455_017178, Mlig455_048127

Neo: Int S/G2/M

Age: -

PCGF1 1.807 - - - 0.969 0.838 -

Mlig455_017178 {REF} {Length: 1075} {TRANSSPLICED} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=31.7]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=30.3]; zinc-RING finger domain [PF14634.8, score=20.7]; Ring finger domain [PF13639.8, score=19.8]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=18.7]} {Human: ENSG00000115289, PCGF1, polycomb group ring finger 1, [Score=94.4, Expect=5e-23]; ENSG00000278644, PCGF2, polycomb group ring finger 2, [Score=92.4, Expect=9e-22]; ENSG00000277258, PCGF2, polycomb group ring finger 2, [Score=92.4, Expect=9e-22]; ENSG00000269897, COMMD3-BMI1, COMMD3-BMI1 readthrough, [Score=90.5, Expect=1e-20]; ENSG00000168283, BMI1, BMI1 proto-oncogene, polycomb ring finger, [Score=90.1, Expect=5e-21]} {Mouse: ENSMUSG00000069678, Pcgf1, polycomb group ring finger 1, [Score=94.4, Expect=3e-23]; ENSMUSG00000018537, Pcgf2, polycomb group ring finger 2, [Score=92.0, Expect=9e-22]; ENSMUSG00000026739, Bmi1, Bmi1 polycomb ring finger oncogene, [Score=90.1, Expect=3e-21]} {Dmel: FBgn0002283, l(3)73Ah, lethal (3) 73Ah, [Score=81.6, Expect=8e-19]} {Celegans: WBGene00008684, mig-32, [Score=67.8, Expect=3e-13]} {Smed: dd_Smed_v6_3477_0_1, dd_Smed_v6_3477_0_1, [Score=87.8, Expect=2e-21]} {RNA1509_26747} {RNA1310_20203.1, RNA1509_26747} {RNA1509_26747, RNA815_27681}

Mlig455_048127 {REF} {Length: 1650} {TRANSSPLICED} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=31.7]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=30.3]; zinc-RING finger domain [PF14634.8, score=20.7]; Ring finger domain [PF13639.8, score=19.8]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=18.7]} {Human: ENSG00000115289, PCGF1, polycomb group ring finger 1, [Score=94.4, Expect=5e-23]; ENSG00000278644, PCGF2, polycomb group ring finger 2, [Score=92.4, Expect=9e-22]; ENSG00000277258, PCGF2, polycomb group ring finger 2, [Score=92.4, Expect=9e-22]; ENSG00000269897, COMMD3-BMI1, COMMD3-BMI1 readthrough, [Score=90.5, Expect=1e-20]; ENSG00000168283, BMI1, BMI1 proto-oncogene, polycomb ring finger, [Score=90.1, Expect=5e-21]} {Mouse: ENSMUSG00000069678, Pcgf1, polycomb group ring finger 1, [Score=94.4, Expect=3e-23]; ENSMUSG00000018537, Pcgf2, polycomb group ring finger 2, [Score=92.0, Expect=9e-22]; ENSMUSG00000026739, Bmi1, Bmi1 polycomb ring finger oncogene, [Score=90.1, Expect=3e-21]} {Dmel: FBgn0002283, l(3)73Ah, lethal (3) 73Ah, [Score=81.6, Expect=8e-19]} {Celegans: WBGene00008684, mig-32, [Score=67.8, Expect=3e-13]} {Smed: dd_Smed_v6_3477_0_1, dd_Smed_v6_3477_0_1, [Score=87.8, Expect=2e-21]} {RNA1509_26747} {RNA1310_20203.1} {RNA815_27681}
3. MligTC455_32461 372 7.74 Mlig455_066539

Neo: -

Age: Up-Down-Up

BLVRB 0.982 - - - - 0.982 - Mlig455_066539 {REF} {Length: 2393} {TRANSSPLICED} {Pfam: NAD(P)H-binding [PF13460.8, score=112.6]; NmrA-like family [PF05368.15, score=41.6]} {Human: ENSG00000090013, BLVRB, biliverdin reductase B, [RH, Score=64.7, Expect=3e-12]} {Mouse: ENSMUSG00000040466, Blvrb, biliverdin reductase B (flavin reductase (NADPH)), [RH, Score=63.5, Expect=6e-12]} {RNA1509_43611} {RNA1310_56475} {RNA815_16010.1}
4. MligTC455_37960 18230 379.78 Mlig455_067109, Mlig455_067122

Neo: Int S/G2/M

Age: -

UBC 0.965 - - - - 0.965 -

Mlig455_067109 {REF} {Length: 1584} {TRANSSPLICED} {Pfam: Ubiquitin family [PF00240.25, score=550.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=271.1]; Ubiquitin-like domain [PF14560.8, score=102.3]; TANK binding kinase 1 ubiquitin-like domain [PF18396.3, score=73.2]; Ubiquitin-2 like Rad60 SUMO-like [PF13881.8, score=67.9]; Ubiquitin-like domain [PF18037.3, score=62.0]; DUF2407 ubiquitin-like domain [PF10302.11, score=55.0]; Silencing defective 2 N-terminal ubiquitin domain [PF13019.8, score=38.1]; Toluene-4-monooxygenase system protein B (TmoB) [PF06234.14, score=35.8]; FlgD Ig-like domain [PF13860.8, score=32.8]; Cilia- and flagella-associated protein 298 [PF11069.10, score=30.1]; Staphylokinase/Streptokinase family [PF02821.18, score=30.0]; Crinkler effector protein N-terminal domain [PF20147.1, score=29.7]; Ubiquitin-like domain [PF18036.3, score=28.7]; UDP-glucose:Glycoprotein Glucosyltransferase [PF06427.13, score=25.0]; GDYXXLXY protein [PF14345.8, score=24.4]; Domain of Unknown Function with PDB structure (DUF3861) [PF12977.9, score=22.8]; Protein of unknown function (DUF969) [PF06149.14, score=22.4]; Rubisco accumulation factor 1 helix turn helix domain [PF18579.3, score=21.0]; Bacterial Ig domain [PF17957.3, score=20.2]; ORF11CD3 domain [PF10549.11, score=19.6]} {Human: ENSG00000150991, UBC, ubiquitin C, [Score=743, Expect=0.0]} {Mouse: ENSMUSG00000008348, Ubc, ubiquitin C, [Score=744, Expect=0.0]} {Dmel: FBgn0086558, Ubi-p5E, Ubiquitin-5E, [Score=744, Expect=0.0]} {Celegans: WBGene00006727, ubq-1, Polyubiquitin-A Ubiquitin Ubiquitin-related, [Score=733, Expect=0.0]} {Smed: dd_Smed_v6_1697_0_2, dd_Smed_v6_1697_0_2, [RH, Score=164, Expect=1e-50]} {RNA1509_199} {RNA1310_58147} {RNA815_13907}

Mlig455_067122 {REF} {Length: 1357} {TRANSSPLICED} {Pfam: Ubiquitin family [PF00240.25, score=443.4]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=220.3]; Ubiquitin-like domain [PF14560.8, score=85.2]; TANK binding kinase 1 ubiquitin-like domain [PF18396.3, score=61.4]; Ubiquitin-2 like Rad60 SUMO-like [PF13881.8, score=57.1]; Ubiquitin-like domain [PF18037.3, score=52.8]; DUF2407 ubiquitin-like domain [PF10302.11, score=45.9]; Silencing defective 2 N-terminal ubiquitin domain [PF13019.8, score=32.4]; FlgD Ig-like domain [PF13860.8, score=31.0]; Toluene-4-monooxygenase system protein B (TmoB) [PF06234.14, score=30.1]; Ubiquitin-like domain [PF18036.3, score=27.4]; Crinkler effector protein N-terminal domain [PF20147.1, score=26.9]; Staphylokinase/Streptokinase family [PF02821.18, score=25.8]; Cilia- and flagella-associated protein 298 [PF11069.10, score=25.6]; UDP-glucose:Glycoprotein Glucosyltransferase [PF06427.13, score=21.2]; GDYXXLXY protein [PF14345.8, score=21.1]; Domain of Unknown Function with PDB structure (DUF3861) [PF12977.9, score=20.4]; Protein of unknown function (DUF969) [PF06149.14, score=18.8]} {Human: ENSG00000150991, UBC, ubiquitin C, [RH, Score=596, Expect=0.0]} {Mouse: ENSMUSG00000019505, Ubb, ubiquitin B, [RH, Score=596, Expect=0.0]} {Dmel: FBgn0086558, Ubi-p5E, Ubiquitin-5E, [Score=596, Expect=0.0]} {Celegans: WBGene00006727, ubq-1, Polyubiquitin-A Ubiquitin Ubiquitin-related, [Score=585, Expect=0.0]} {Smed: dd_Smed_v6_1697_0_2, dd_Smed_v6_1697_0_2, [RH, Score=164, Expect=2e-51]} {RNA1509_199} {RNA1310_58147} {RNA815_13907}
5. MligTC455_28518 184 3.84 Mlig455_068682

Neo: -

Age: Down-Down-Up

ANKRD50 0.95 - - - - 0.950 - Mlig455_068682 {REF} {Length: 5526} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=230.6]; Ankyrin repeats (many copies) [PF13637.8, score=137.6]; Ankyrin repeat [PF00023.32, score=109.8]; Ankyrin repeats (many copies) [PF13857.8, score=106.4]; Ankyrin repeat [PF13606.8, score=102.1]; Mab-21 protein [PF03281.16, score=30.7]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=158, Expect=1e-38]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=157, Expect=2e-38]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=135, Expect=8e-33]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=134, Expect=1e-31]} {Smed: dd_Smed_v6_6201_0_1, dd_Smed_v6_6201_0_1, [Score=140, Expect=6e-34]} {RNA1509_18101} {RNA1310_3035.1, RNA1509_18101} {RNA1509_18101, RNA815_4096}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA